GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Glenmark Life Sciences Ltd (NSE:GLS) » Definitions » Net Income Including Noncontrolling Interests

Glenmark Life Sciences (NSE:GLS) Net Income Including Noncontrolling Interests : ₹4,235 Mil (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Glenmark Life Sciences Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Glenmark Life Sciences's Net Income Including Noncontrolling Interests for the three months ended in Sep. 2024 was ₹953 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Sep. 2024 was ₹4,235 Mil.

Glenmark Life Sciences Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Glenmark Life Sciences's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Glenmark Life Sciences Net Income Including Noncontrolling Interests Chart

Glenmark Life Sciences Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Net Income Including Noncontrolling Interests
Get a 7-Day Free Trial 3,130.98 3,515.81 4,187.24 4,669.61 4,708.88

Glenmark Life Sciences Quarterly Data
Mar19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,187.37 1,187.65 979.36 1,114.83 953.16

Glenmark Life Sciences Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹4,235 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Glenmark Life Sciences Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Glenmark Life Sciences's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

Glenmark Life Sciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Glenmark Life Sciences Ltd (NSE:GLS) » Definitions » Net Income Including Noncontrolling Interests
Comparable Companies
BOM:524742 BOM:532872 BOM:532482 BOM:500126 BOM:530019 BOM:531599 BOM:524558 NSE:STAR BOM:524348 BOM:540596 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
543322:India
Address
470, Cardinal Gracious Road, 4th Floor, OIA House, Andheri (East), Mumbai, MH, IND, 400099
Website
https://www.glenmarklifesciences.com
Glenmark Life Sciences Ltd develops, manufactures, and supplies high-quality active pharmaceutical ingredients for cardiovascular disease, central nervous system disease, pain management, and diabetes, gastrointestinal disorders, anti-infectives, and other therapeutic areas.

Glenmark Life Sciences Headlines

No Headlines